Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
UPDATE: JP Morgan Downgrades Underweight on Myriad Genetics on Risk/Reward
Latest Articles from Benzinga.com
Posted on January 03, 2013 at 08:40 AM EST
JP Morgan reduced its rating on Myriad Genetics (NASDAQ: MYGN ) from Neutral to Underweight while reiterating its $26 price target. JP Morgan commented, "We see the investor debate in 2013 for Myriad Genetics (MYGN) as being
Read More >>
Myriad Genetics, Inc.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here